{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "18",
          "submission_status": "AP",
          "submission_status_date": "20260127",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "84849",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/209401Orig1s018ltr.pdf",
              "date": "20260128",
              "type": "Letter"
            },
            {
              "id": "84859",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2026/209401s018lbl.pdf",
              "date": "20260128",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20210330",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "66924",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/209401s006lbl.pdf",
              "date": "20210330",
              "type": "Label"
            },
            {
              "id": "66933",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/209401Orig1s006ltr.pdf",
              "date": "20210331",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20200113",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "61559",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/209401Orig1s002ltr.pdf",
              "date": "20200114",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20170803",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 4",
          "submission_class_code_description": "Type 4 - New Combination",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "49218",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209401s000lbl.pdf",
              "date": "20170803",
              "type": "Label"
            },
            {
              "id": "49243",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209401Orig1s000ltr.pdf",
              "date": "20170804",
              "type": "Letter"
            },
            {
              "id": "53816",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/209401Orig1s000TOC.html",
              "date": "20180425",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "11",
          "submission_status": "AP",
          "submission_status_date": "20220927",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "72169",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/209401Orig1s011ltr.pdf",
              "date": "20220928",
              "type": "Letter"
            },
            {
              "id": "72174",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209401s011lbl.pdf",
              "date": "20220928",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA209401",
      "sponsor_name": "JAZZ PHARMS THERAP",
      "openfda": {
        "application_number": [
          "NDA209401"
        ],
        "brand_name": [
          "VYXEOS"
        ],
        "generic_name": [
          "(DAUNORUBICIN AND CYTARABINE) LIPOSOME"
        ],
        "manufacturer_name": [
          "Jazz Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "68727-745"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "CYTARABINE",
          "DAUNORUBICIN"
        ],
        "rxcui": [
          "1942743",
          "1942748"
        ],
        "spl_id": [
          "25abb1d8-f921-4aae-8240-1914cd80417a"
        ],
        "spl_set_id": [
          "7ea701ce-e7d3-4349-a9c2-642a501d45c8"
        ],
        "package_ndc": [
          "68727-745-05",
          "68727-745-02",
          "68727-745-01"
        ],
        "nui": [
          "N0000000233",
          "N0000175595",
          "N0000175414",
          "M0028312",
          "N0000000176"
        ],
        "pharm_class_moa": [
          "Nucleic Acid Synthesis Inhibitors [MoA]",
          "Topoisomerase Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Nucleoside Metabolic Inhibitor [EPC]",
          "Anthracycline Topoisomerase Inhibitor [EPC]"
        ],
        "pharm_class_cs": [
          "Anthracyclines [CS]"
        ],
        "unii": [
          "04079A1RDZ",
          "ZS7284E0ZP"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "VYXEOS",
          "active_ingredients": [
            {
              "name": "CYTARABINE",
              "strength": "100MG"
            },
            {
              "name": "DAUNORUBICIN",
              "strength": "44MG"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}